Bourhis J-H, Bouko Y, Koscielny S, Bakkus M, Greinix H, Derigs G, Salles G, Feremans W, Apperley J, Samson D, Björkstrand B, Niederwieser D, Gahrton G, Pico J-L, Goldschmidt H. Relapse risk after autologous transplantation in patients with newly diagnosed myeloma is not related with infused tumor cell load and the outcome is not improved by CD34+ cell selection: long term follow-up of an EBMT phase III randomized study. Haematologica [Internet]. 2007Aug.1 [cited 2026Nov.11];92(8):1083-90. Available from: https://haematologica.org/article/view/4537